Court dockets these days are full of free - speech challenges
from pharmaceutical firms, tobacco companies, miners, meat producers and airlines.
A drug delivery shortfall
from pharmaceutical firm Sandoz Canada is expected to affect the drug supply (for anywhere from a few weeks to a couple of months) of many common injectable medications in hospitals across the country.
Not exact matches
On average, the 30 large and small
pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue
from drugs developed within the past five years, says Mike Rea, the
firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.
If you haven't followed this story, you'll remember Shkreli
from his fame two years ago, when his biotech
firm, Turing
Pharmaceuticals, acquired the patent to a drug used to treat malaria, cancer and aids, and jacked up the retail price by more than 5,000 percent.
Many biotech and
pharmaceutical firm won't gain much
from the new corporate tax rate, but they'll benefit
from being able to access overseas cash.
The
firm is currently fielding both a federal lawsuit in Texas centering on Restasis as well as challenges
from would - be competitors like Teva, Mylan
Pharmaceuticals, and Akorn through the U.S. Patent and Trade Office's inter partes review (IPR) process.
«That conservatism has been present through my entire career,» says McNally, now the president of Laval, Que.,
firm Équipement d'emballage MMC (a.k.a., MMC Packaging), which designs and builds automated machinery for companies that manufacture plastic caps and lids for anything
from food products, to
pharmaceuticals, to agricultural chemicals.
There were $ 221 billion worth of
pharmaceutical deals completed in the first half of this year, triple the amount during the first half of 2014, according to a recent report
from consulting
firm KPMG.
The latest episode began June 27, affecting companies worldwide
from Russian oil
firm Rosneft to U.S.
pharmaceutical company Merck.
Many of the highest earners among organizations in the Standard & Poor's 500 index are healthcare and
pharmaceutical company CEOs, according to a report
from the Associated Press and research
firm Equilar.
In the letter, the antitrust bureau chief for New York Attorney General Eric Schneiderman asked Shkreli to contact the office «immediately» to respond to concerns that the company's sales practices were intended to deter generic
pharmaceutical firms from creating alternatives to the drug.
The Wall Street Journal reported late Thursday afternoon that prior to hiring Joseph Papa as CEO, Valeant
Pharmaceuticals Intl Inc (NYSE: VRX) received an acquisition proposal
from Japan's Takeda Pharmaceutical and private equity
firm TPG.
Judging
from the latest round of spats in the press between Canadian dairy farmers and autoworkers,
pharmaceutical firms and Eastern European countries, it's safe to say that there is still much work to be done before all signing parties are satisfied.
Gadhok joined
pharmaceutical firm Bayer earlier this year
from Four Communications, where he was a director.
Rep. Chris Collins dramatically increased his campaign fundraising in the first half of the year, and he took more money
from health care and
pharmaceutical companies than any other special interest at a time when he's under investigation for his ties to an Australian biotech
firm.
Competing in that single market with the best companies in the world drives competitiveness and innovation for
firms in all parts of our economy:
from cars to computers, phones to
pharmaceuticals.
Midtown - based investment
firm Gaia Real Estate acquired the 50th floor of the Bernard Spitzer - developed Corinthian condominium tower in Murray Hill
from pharmaceutical giant Pfizer,...
Collins took money
from groups representing anesthesiologists, cardiologists, dentists, dermatologists, hospitals, neurologists, oncologists, optometrists, psychiatrists, radiologists, physicians assistants, pain physicians, renal physicians and urologists, as well as PACS representing several
pharmaceutical and biomedical
firms.
WASHINGTON — Rep. Chris Collins dramatically increased his campaign fundraising in the first half of the year, and he took more money
from health care and
pharmaceutical companies than any other special interest at a time when he's under investigation for his ties to an Australian biotech
firm.
«The data
from a publicly funded study may be good, but you don't have anyone out there pushing that study data, versus thousands of people doing it for the drug companies,» says Kevin Brode, a former vice president at marketRx, a
firm that provides strategic marketing information to the
pharmaceutical industry.
$ 73.9 BILLION Average amount spent yearly on «marketing and administration» by 10 major
pharmaceutical firms from 1996 through 2005, according to a report
from the University of Quebec at Montreal.
Then immunotherapy
firm Juno Therapeutics shook hands with gene - editing start - up Editas to create anticancer immune cell therapies; Vertex
Pharmaceuticals and Crispr Therapeutics, another start - up, inked an agreement that could be valued at $ 2.6 billion; while Regeneron
Pharmaceuticals formed a patent licence agreement with ERS Genomics, which holds the rights to the foundational Crispr intellectual property
from Emmanuelle Charpentier, one of the Crispr pioneers.
The
firm, Beta Bionics, quickly secured $ 5 million in funding
from Eli Lilly and Co., the
pharmaceutical giant.
Meanwhile, a report
from the McKinsey Global Institute, a consulting
firm, says that businesses spanning virtually all sectors —
from technology and social networking to
pharmaceuticals and health care — are using information gleaned
from large data sets to help them operate more smoothly or to provide better products or services.
The United Kingdom is stepping in to protect an ailing
pharmaceutical research
firm from attacks and intimidation by animal rights protestors.
Today, scientists targeting industry can choose
from a variety of specialized training courses, which can make a big difference in their «marketability» for jobs at biotechnology,
pharmaceutical, medical device, and other
firms offering scientific employment opportunities.
Here he plays Harold, a decent but all - too - credulous immigrant
from Nigeria who works as a manager in the Chicago
pharmaceuticals firm of which Edgerton and Theron are co-CEOs.
Charles Johnson, a partner at Butler Snow, says the Jackson, Mississippi - based
firm is handling an increasing amount of work
from longtime
pharmaceutical clients, including Johnson & Johnson and Merck.
«The most successful law
firms are the ones who just get on with it — they stop talking about it and actually start experimenting — very much in the R&D spirit of consumer electronics and
pharmaceutical industry where these businesses don't know where their income is coming
from in five years time so they engage in R&D.
The attorneys at our
firm have also represented clients in a variety of other class action cases, ranging
from mass tort litigation, including asbestos claims, to
pharmaceutical and medical devices.
Mr. Budd, a shareholder of Baron & Budd since 1985 and president and managing shareholder since 2002, has expanded the
firm from its cornerstone asbestos practice to a national
firm capable of tackling the biggest defendants in areas as diverse as
pharmaceutical and medical device injury, water contamination, BP Gulf oil spill, financial fraud and various other areas of practice.
Indeed, one needs to appreciate the very peculiar features prevailing in the pharma sector and the potential conflict between competition law and IPRs, which results
from the fact that - as a rule -
pharmaceutical firms enjoy patent protection.
His experience in these areas stems
from his time at the venerated plaintiffs» law
firm Lopez, Hodes, Restaino, Milman & Skikos, where he handled high - profile mass tort litigation and
pharmaceutical injury cases against such behemoth companies as Wal - mart, Merck & Co. and Halliburton Company.
Our reputation as one of the top class action defense
firms in the country results
from our significant experience in defending against alleged class actions across a broad range of
pharmaceutical and other products litigation, as well as antitrust, employment and securities litigation.
The
firm's experience of dealing with the full range of employment issues that arise both domestically and internationally have led Square One Law to be appointed to manage the employment needs of a multinational
pharmaceutical company on all jurisdictions aside
from India.
Working with only very best clients - ranging
from global
pharmaceutical firms to Investment banking funds
Join the graduate scheme as a trainee recruitment consultant at an established and highly - regarded Life Sciences recruitment
firm with an amazing client base, ranging
from big
pharmaceutical firms (like GSK, Pfizer, AstraZeneca), small - mid sized bio farmers...